Majority of older adults with cognitive impairment still drive

Researchers highlight the importance of caregivers having conversations with care recipients and health care professionals about driving

5:00 AM

Author | Noah Fromson

brain image
Justine Ross, Jacob Dwyer, Michigan Medicine

The majority of older adults with cognitive impairment are still driving, despite concerns raised by caregivers and others, a Michigan Medicine study in a South Texas community finds.

Researchers assessed more than 600 adults over 65 years old in Nueces County, Texas, who had cognitive assessment scores that indicated a likelihood of impairment.

Of those people with cognitive impairment, 61.4% were current drivers, and around one-third of all caregivers had concerns about their care-recipient driving. The results are published in the Journal of the American Geriatrics Society.

“It is likely appropriate that some with mild cognitive impairment are still driving, but for some it may not be,” said senior author Lewis B. Morgenstern, M.D., professor of neurology, neurosurgery and emergency medicine at University of Michigan Medical School and professor of epidemiology at the U-M School of Public Health.

“Patients and caregivers should discuss these issues with their health care providers and consider on the road driving evaluations to ensure safety.”

SEE ALSO: 1 in 10 older Americans has dementia

Approximately one in nine Americans aged 65 and older, or 6.7 million people, are estimated to live with Alzheimer’s disease and millions more have related dementias.

These conditions may affect neuropsychological and visual skills that reduce the ability to drive safely. A 2017 review of motor vehicle crash risk found that dementia had medium to large effects on driving impairment and that people with dementia have an increased likelihood of failing a road test compared to those without.

Investigators initially set out to study the driving prevalence of older Latino and non-Latino white adults, finding no significant differences between the two populations. However, the more cognitive impairment any individual had, the less likely they were to be driving.

SEE ALSO: What is frontotemporal dementia? A neurologist explains

Just over 35% of caregivers had concerns about their care recipient’s ability to drive safely, even though many study participants limited their total amount of driving and avoided driving at night or in the rain.

The discussions between caregivers and people with cognitive impairment about driving are difficult, with concerns over the loss of autonomy and potential embarrassment. When a person with cognitive impairment stops driving, that may also increase the workload of a caregiver.

Researchers say it’s best to start conversations surrounding driving earlier while the care recipient is able to understand and actively participate in the discussion.

“Close family may have discussions with aging loved ones about Advance Driving Directives,” Morgenstern said. “These are agreements between an aging person and a loved one about having conversations about driving cessation.”

Click here for more information from the NIH on safe driving for older adults.

Additional authors include Madelyn Malvitz, Darin B. Zahuranec, M.D., Wen Chang, Steven G. Heeringa, Ph.D., Emily M. Briceño, Ph.D., Roshanak Mehdipanah, Ph.D., Deborah A. Levine, M.D., Kenneth M. Langa, M.D., Ph.D., Nelda Garcia, all of University of Michigan, and Xavier F. Gonzales, Ph.D., of Texas A&M, Corpus Christi.

This research was supported by the National Institute of Neurological Disorders & Stroke and the National Institute on Aging at the National Institutes of Health (grants R01NS100687, R01AG069148, and P30AG024824)

The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Kenneth M. Langa receives grant funding from the NIA and Alzheimer's Association and consults on NIH-funded projects related to identifying dementia in population-based studies. Lewis B. Morgenstern, Emily M. Briceño, Roshanak Mehdipanah, Deborah A. Levine, Darin B. Zahuranec, and Steven G. Heeringa receive grant funding from the NIH.

Paper cited: “Driving predictors in a cohort of cognitively impaired Mexican American and non-Hispanic White individuals,” Journal of the American Geriatrics Society. DOI: 10.1111/jgs.18493


More Articles About:

Neurological (Brain) Conditions Alzheimer's Disease Neurodegenerative Disorder Neurological Disorders Community Health Preventing Injury
Health Lab word mark overlaying blue cells

Health Lab

Explore thousands of health news & research stories by visiting the Health Lab homepage for more.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

Minding Memory with a microphone and a shadow of a microphone on a blue background
Minding Memory

Antipsychotic Use in Nursing Homes: Balancing Medication Safety, Policy, and Dementia Care

In this episode, Lauren Gerlach and Matt Davis speak with Theresa Shireman, PhD, Director of the Center for Gerontology and Healthcare Research and a Professor of Health Services, Policy and Practice and Epidemiology at the Brown University School of Public Health. Dr. Shireman’s research focuses on pharmaceutical policy, pharmacoepidemiology, health services research, and medication use among vulnerable populations. Dr. Shireman discusses her recent study, "Impact of Federal Antipsychotic Use Policy in Nursing Homes on New Diagnoses for Approved Indications in Dementia Residents," published in the Journal of the American Geriatrics Society. The study examines whether federal policies designed to reduce antipsychotic use in nursing homes were associated with increases in new diagnoses of conditions, such as schizophrenia, that exclude residents from publicly report antipsychotic quality measures. Using an interrupted time-series design, the researchers examined changes following the 2012 National Partnership to Improve Dementia Care and the 2015 addition of antipsychotic use to the Nursing home Five-Star Quality Rating System. They found that neither policy was associated with an increase in new exclusionary diagnossees, challenging concerns that nursing homes were increasingly assigning these diagnoses to circumvent restrictions on antipsychotic use. The conversation also explores the benefits and risks of antipsychotic medications for people living with dementia, including the potential for serious adverse effects such as sedation, falls, stroke, and increased mortality. Dr. Shireman discusses how public reporting and financial incentives can influence prescribing practices,the limitations of using a single quality measure to evaluate nursing home care, and the importance of balancing medication safety and residents’ individual needs. The discussion highlights the need for shared decision-making among clinicians, nursing home staff, residents, and families, as well as greater investment in staffing, resources, and nonpharmacological approaches to improve quality of life for people living with dementia. The transcript for this episode can be found here.
Health Lab

4 ways to teach your teen safe driving habits

New motorists cause a disproportionate number of distracted driving accidents. That’s why laying the groundwork for safe habits must begin before your teen gets the keys.
Graphic of parents stressed about bills
Health Lab

4 in 5 parents say having a baby is too expensive

Four in five parents say it costs too much to have a baby, according to the University of Michigan Health C.S. Mott Children’s Hospital National Poll on Children’s Health.
pills close up some powder some round some long
Health Lab

What’s the latest on 7-OH and kratom availability and addiction care?

The United States Drug Enforcement Agency has announced it will place non-botanical products containing 7-OH on Schedule I, joining three other synthetic opioids, effectively removing them the market, leaving natural leaf kratom available amid a shortage of addiction treatment providers.
Minding memory above a microphone on a blue background
Minding Memory

Can Your Voice Reveal Early Signs of Alzheimer’s?

In this episode, Lauren & Matt speak with Neguine Rezaii, MD, an Assistant Professor of Neurology at Harvard Medical School and a Board-Certified Neuropsychiatrist at Mass General Hospital. Dr. Rezaii’s research focuses on using natural language processing and artificial intelligence to improve the detection and classification of neurodegenerative disorders. Dr. Rezaii talks about her recent study, “Voiceprints of Cognitive Impairment: Analyzing Digital Voice for Early Detection of Alzheimer’s and Related Dementias,” which explores how artificial intelligence can analyze short speech samples to identify subtle signs of cognitive impairment. The study used speech recordings from 120 individuals and found that features such as pauses, word choice and the specificity of language can help distinguish cognitive impairment and Alzheimer’s disease. The conversation also explores how a simple 30-second speech test could potentially be used in clinical settings to support earlier detection and monitoring of cognitive impairment, as well as the challenges and ethical considerations that come with using AI to analyze something as personal as a person’s voice.
Cole, wearing sunglasses and a purple Calming the Storm t-shirt with a rainbow, is seated on a blanket outdoors and holding a Mott teddy bear.
Philanthropy News

A pediatric epilepsy fundraiser that changes lives

Your support of Calming the Storm advances pediatric epilepsy research and patient care programs. There are many ways you can contribute to make a difference for so many children and families.